We are live on ! Find out more
JSPRW icon

Japer Therapeutics Warrants
JSPRW

25 hedge funds and large institutions have $3.37M invested in Japer Therapeutics Warrants in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 1

81% more capital invested

Capital invested by funds: $1.86M → $3.37M (+$1.5M)

39% more funds holding

Funds holding: 18 → 25 (+7)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
25
Holders Change
+7
Holders Change %
+38.89%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
1
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
Bulldog Investors
New Jersey
+$58.5K
2
LIM
Longfellow Investment Management
Massachusetts
+$58.4K
3
BCM
Beryl Capital Management
California
+$40.9K
4
PC
Periscope Capital
Ontario, Canada
+$31.3K
5
BFM
Boothbay Fund Management
New York
+$18.9K

Top Sellers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
-$64.1K
2
CAC
Cowen and Company
New York
-$36.8K
3
MSU
Mizuho Securities USA
New York
-$11K
4
BCM
Basso Capital Management
Connecticut
-$5.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
OCAM
1
Owl Creek Asset Management
New York
$681K – – –
SRCM
2
Sage Rock Capital Management
New York
$513K – – –
BFM
3
Boothbay Fund Management
New York
$311K +$18.9K +30,300 New
TCM
4
Tenor Capital Management
New York
$250K – – –
PMAM
5
Picton Mahoney Asset Management
Ontario, Canada
$192K – – –
AA
6
AQR Arbitrage
Connecticut
$188K – – –
PAMP
7
Polar Asset Management Partners
Ontario, Canada
$162K – – –
GCL
8
Glazer Capital LLC
New York
$130K – – –
MS
9
Maven Securities
Jersey
$100K – – –
LIM
10
Longfellow Investment Management
Massachusetts
$96K +$58.4K +93,887 New
BI
11
Bulldog Investors
New Jersey
$94K +$58.5K +93,958 New
MIM
12
Monashee Investment Management
Massachusetts
$88K – – –
Verition Fund Management
13
Verition Fund Management
Connecticut
$83K – – –
AIMCA
14
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$80K – – –
WAM
15
Wolverine Asset Management
Illinois
$72K +$11.1K +17,772 +32%
LA
16
Linden Advisors
New York
$69K – – –
BCM
17
Beryl Capital Management
California
$66K +$40.9K +65,662 New
PC
18
Periscope Capital
Ontario, Canada
$52K +$31.3K +50,200 New
AGM
19
Alpine Global Management
New York
$51K – – –
BCM
20
Basso Capital Management
Connecticut
$26K -$5.8K -9,313 -26%
CAPTRUST Financial Advisors
21
CAPTRUST Financial Advisors
North Carolina
$21K +$13.6K +21,820 New
Geode Capital Management
22
Geode Capital Management
Massachusetts
$15K -$64.1K -103,000 -86%
CAC
23
Cowen and Company
New York
$15K -$36.8K -59,103 -80%
EIP
24
Easterly Investment Partners
Massachusetts
$10K +$6.22K +10,000 New
MSU
25
Mizuho Securities USA
New York
– -$11K -16,558 Closed
1
2

JSPRW Hedge Fund Activity: Q2 2020 in Review

25 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Japer Therapeutics Warrants (JSPRW) for Q2 2020, worth a combined $3.37M — up 81% from $1.86M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new JSPRW positions and 1 closed out — a net gain of 7 holders — while 1 added to existing stakes and 3 trimmed.

The largest buyer was Bulldog Investors, opening a new position worth an estimated $58.5K. The largest seller was Geode Capital Management, cutting an estimated $64.1K.

  • 25 institutional investors held Japer Therapeutics Warrants (JSPRW) as of Q2 2020, up from 18 in Q1 2020.
  • Funds reported $3.37M of Japer Therapeutics Warrants stock for Q2 2020, up 81% quarter-over-quarter.
  • 8 funds opened new Japer Therapeutics Warrants positions in Q2 2020 and 1 closed out, a net change of +7 holders.
  • The largest Japer Therapeutics Warrants buyer in Q2 2020 was Bulldog Investors, an estimated $58.5K added.
  • The largest Japer Therapeutics Warrants seller in Q2 2020 was Geode Capital Management, an estimated $64.1K sold.

Based on aggregated 13F filings for Q2 2020.